The United States has announced a trade agreement with the United Kingdom that eliminates tariffs on pharmaceutical products and medical technologies. In return, the United Kingdom will increase the percentage of the NHS budget allocated to medications and will pay 25% more for new drugs. The agreement aims to stimulate investment and innovation in both countries, according to U.S. Trade Representative Jamieson Greer. A change in the assessment of therapy value by NICE is also expected, which will modify the threshold used to determine the effectiveness of medications. The U.S. has pressured the UK to pay more for American drugs, and the pharmaceutical industry has expressed dissatisfaction with the conditions in the United Kingdom. London has committed to reducing the reimbursement rate to 15% starting in 2026.
Sources
Latest News
21:56
SNSPA launches center for youth addictions / New structure to develop prevention and reintegration policies
21:50
Emmanuel Macron calls a crisis meeting after protests over education conditions spread
21:48
A Romanian man was detained in Italy after fleeing the scene of an accident in which a young woman died
21:44
Nicușor Dan discussed Romania’s priorities at the European Council meeting on October 15–16 with Antonio Costa
21:44
The Oradea Local Council approves the sale of a plot of land for the Schmitz Cargobull factory, an investment of at least 25 million euros
See more news